Innovative technologies in diabetes management
Barsukov I.A., Demina A.A.
Diabetes mellitus (DM) is a major global problem characterized by a steady increase in incidence and a high rate of undiagnosed cases. Epidemiological data indicate that the actual number of patients with diabetes may significantly exceed official statistics, which is also relevant for Russia. Diabetes management options are significantly expanding due to digital technologies, which create a holistic care ecosystem. Continuous glucose monitoring (CGM) systems, which allow for the assessment of glycemic variability throughout the day, play a key role. The integration of CGM with insulin pumps has led to the development of automated insulin delivery systems. These systems use algorithms to autonomously adjust insulin doses, improving glycemic outcomes and reducing patient burden. For patients on injection therapy, smart syringe pens improve adherence through reminders and accurate dose recording. Telemedicine platforms and mobile apps provide remote monitoring and consulting support, overcoming geographic barriers. In the Russian Federation, these trends are being implemented as part of government initiatives to digitalize healthcare, aimed at introducing personal monitoring devices. Along with CGM systems and automated insulin pumps, smart glucometers integrated into mobile apps are becoming an important element of the digital ecosystem. A prominent example of such a solution on the Russian market is the Glucocard Σ+ Link glucometer. This device combines high measurement accuracy with automatic data transfer via Bluetooth to the WeCheck Diabetes mobile app. This allows patients to keep an electronic self-monitoring diary, analyze trends, and remotely share results with their physician. Thus, the widespread adoption of digital solutions is a decisive factor in improving patients’ quality of life, improving clinical prognoses, and building a more effective diabetes care system.
For citations: Barsukov I.A., Demina A.A. Innovative technologies in diabetes management. Pharmateca. 2025;32(8):44-50. (In Russ.). DOI: https://dx.doi.org/10.18565/pharmateca.2025.8.44-50
Authors’ contribution: All authors approved the final version of the article before publication and agreed to be accountable for all aspects of the work, including appropriately reviewing and resolving any questions related to the accuracy or integrity of any part of the work.
Conflicts of interest: The authors confirm that they have no conflicts of interest to declare.
Funding: The study was conducted without any sponsorship.
Keywords
diabetes mellitus
self-monitoring of blood glucose
continuous glucose monitoring
About the Authors
Ilya A. Barsukov, Cand. Sci. (Med.), Senior Researcher, Department of Therapeutic Endocrinology, M.F. Vladimirsky Moscow Regional Clinical Research Institute; Chief Specialist in Endocrinology, Network of Federal Centers, MEDSI Group of Companies, Moscow, Russia; palantirr@inbox.ru, ORCID: https://orcid.org/0000-0002-1889-8555, Scopus Author ID: 57225446501, eLibrary SPIN: 7946-8566 (corresponding author)Anna A. Demina, Researcher, Department of Therapeutic Endocrinology, M.F. Vladimirsky Moscow Regional Clinical Research Institute, Moscow, Russia; annagalitskova@gmail.com, ORCID: https://orcid.org/0000-0002-7742-5782, Scopus Author ID: 58318134200, eLibrary SPIN: 2345-6369
Similar Articles
